A Biphasic Tumor of the Mediastinum with Features of Synovial Sarcoma

1989 ◽  
Vol 13 (6) ◽  
pp. 490-499 ◽  
Author(s):  
Gary B. Witkin ◽  
Markku Miettinen ◽  
Juan Rosai
Author(s):  
Anuradha Sekaran ◽  
Purva Shinde ◽  
Veena Vanere ◽  
Mohan Ramchandani ◽  
Duvvur N. Reddy

Synovial sarcoma (SS) in young adult mainly involves periarticular region of the extremities. Synovial sarcomas are exceedingly rare neoplasms of the digestive tract. In this report, we describe a very rare occurrence of primary SS of the esophagus in a 30-year-old female. Patient presented with dysphagia. Endoscopy showed submucosal esophageal polyp. Piecemeal polypectomy was done. Histologically, the tumor demonstrated biphasic morphology with epithelial and mesnchymal component. Tumor cells expressed pancytokeratin, bcl-2 and CD99 antigens. Differential diagnosis of synovial sarcoma and epithelial mesenchymal biphasic tumor was made. Cytogenetics was done to confirm the diagnosis of SS. It showed translocation (x;18). Synovial sarcomas are very rare tumor entities, particularly in the gastrointestinal tract and are likely to be mistaken with other more common tumors such as gastrointestinal stromal tumors.


Author(s):  
Amrit Kaur Kaler, Shweta C, Smitha Chandra B.C, Rajeev Naik

Spindle cell carcinoma is a rare aggressive biphasic tumor, composed of neoplastic proliferation of both epithelial (squamous) and spindle cell population. It constitutes about 1% of all oral cavity tumors 2a and is almost rare on the tongue; only few cases have been reported so far. This variant of squamous cell carcinoma, comprises major diagnostic problems due to its varied histomorphology and resemblance to sarcomatous lesion; hence diligent screening and IHC markers are mandatory for its diagnosis.


2020 ◽  
Vol 16 (35) ◽  
pp. 2997-3013
Author(s):  
Kentaro Kogushi ◽  
Michael LoPresti ◽  
Shunya Ikeda

Background: Synovial sarcoma (SS) is a rare, aggressive soft tissue sarcoma with a poor prognosis after metastasis. The objective of this study was to conduct a systematic review of the clinical evidence for therapeutic options for adults with metastatic or advanced SS. Materials & methods: Relevant databases were searched with predefined keywords. Results: Thirty-nine publications reported clinical data for systemic treatment and other interventions. Data on survival outcomes varied but were generally poor (progression-free survival: 1.0–7.7 months; overall survival: 6.7–29.2 months) for adults with metastatic and advanced SS. A high frequency of neutropenia with systemic treatment and low quality of life post-progression were reported. Conclusion: Reported evidence suggests poor outcomes in adults with metastatic and advanced SS and the need for the development of new treatment modalities.


2015 ◽  
Vol 9 (5) ◽  
pp. 1947-1949 ◽  
Author(s):  
HIROAKI SATOH ◽  
NORIO TAKAYASHIKI ◽  
TOSHIHIRO SHIOZAWA ◽  
KUNIHIKO MIYAZAKI ◽  
GEN OHARA ◽  
...  
Keyword(s):  

1981 ◽  
Vol 9 (1) ◽  
pp. 41-45 ◽  
Author(s):  
R. Beverly Raney
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document